Most just lately, it's been discovered that conolidine and the above derivatives act to the atypical chemokine receptor 3 (ACKR3. Expressed in comparable areas as classical opioid receptors, it binds to a big range of endogenous opioids. Unlike most opioid receptors, this receptor functions being a scavenger and won't activate a second messenger pr… Read More